The researchers said that the methylation mark could potentially be used as a noninvasive biomarker for certain tumor types.
Using whole-exome sequencing early in the diagnostic process could save $3,500 on average in patients who obtain a diagnosis from it and $1,700 in patients who do not.
Two separate studies concluded that in most SEO cancer cases what they are seeing are two separate early-stage tumors, instead of late-stage cancer.
The researchers said the technique could be used to identify biomarkers specific to cancer or bacterial infection that are too small to detect by other methods.
The researchers found evidence of a single major dispersal event in non-African populations, and discovered an unknown European population turnover.
In Science this week: experts say race is not a sufficient proxy for studying human genetic diversity and more.
Technology Review writes that CRISPR/Cas9 gene editing firm Editas' success may hinge on a patent case.
Researchers unearthed a bioinformatics error in the Science paper reporting the first ancient African genome, and the authors are seeking an erratum.
A boy's cystic fibrosis carrier status was revealed by a teacher to the parents of children with CF who then sought the boy's transfer to another school, leading to a lawsuit.
This webinar will demonstrate how ACMG's recommended variant scoring and classification rules may be applied to standardize reporting on sequencing test results within and across institutions.
This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.
This webinar will discuss Qiagen's approach to address two challenges facing NGS in the clinical research setting: lack of seamless workflow for routine clinical research use and truly relevant content to guide clinical research activities.